XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations (Tables)
9 Months Ended
Jun. 30, 2020
Business Acquisition [Line Items]  
Business Acquisition, Pro Forma Information
 
Three Months Ended
June 30,
   
Nine Months Ended
June 30,
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
Net Revenues
  $
85,083
    $
52,319
    $
196,978
    $
160,887
 
Net Earnings
  $
28,189
    $
(9
  $
39,376
    $
5,093
 
Business Acquisition Proforma Adjustments
 
Three Months Ended
 
June 30,
   
Nine Months Ended
June 30,
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
Adjustments to Net Revenues
 
   
   
   
 
Exalenz and GenePOC pre-acquisition revenues
  $
286
    $
3,879
    $
7,464
    $
10,719
 
                                 
Adjustments to Net Earnings
 
 
 
 
 
 
 
 
 
 
 
 
Exalenz and GenePOC pre-acquisition net losses
  $
(4,919
)   $
(3,486
)   $
(6,398
)   $
(12,924
)
Pro forma adjustments:
   
     
     
     
 
Meridian acquisition-related costs
   
1,641
     
—  
     
3,428
     
—  
 
Exalenz and GenePOC transaction-related costs
   
4,104
     
—  
     
4,550
     
—  
 
Remove net impact of non-continuing personnel, locations or activities
   
(447
   
457
     
(305
   
2,949
 
Incremental depreciation and amortization
   
(224
)    
(1,739
)    
(2,016
)    
(4,787
)
Incremental interest costs, net
   
444
     
(599
)    
(183
)    
(1,346
)
Tax effects of pro forma adjustments and recognizing benefit on resulting Exalenz losses
   
83
     
279
     
607
     
922
 
                                 
Total Adjustments to Net Earnings
  $
682
    $
(5,088
)   $
(317
)   $
(15,186
)
                                 
Exalenz [Member]  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
 
PRELIMINARY
 
Fair value of assets acquired -
   
 
Cash
  $
5,006
 
Accounts receivable
   
637
 
Inventories
   
4,329
 
Other current assets
   
851
 
Property, plant and equipment
   
544
 
Goodwill
   
29,288
 
Other intangible assets (estimated useful life):
 
 
 
Non-compete agreement (5 years)
 
 
120
 
Trade name
 
(10 years)
   
3,540
 
Technology (15 years)
   
5,590
 
Customer relationships
(10 years)
   
19,370
 
         
Right-of-use assets
   
1,358
 
Deferred tax assets, net
   
5,566
 
         
 
   
76,199
 
   
Fair value of liabilities assumed -
  
     
Accounts payable and accrued expenses (including current portion of lease and government grant obligations)
  
 
7,757
 
Long-term lease obligations
  
 
1,054
 
Long-term government grant obligations
  
 
10,792
 
Other
non-current
liabilities
  
 
291
 
 
  
 
 
 
 
  
 
19,894
 
 
  
 
 
 
Total consideration paid (including $8,068 to payoff long-term debt)
  
$
56,305
 
 
  
 
 
 
GenePOC Inc [Member]  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The recognized final amounts of identifiable assets acquired and liabilities assumed in the
acquisition
of the GenePOC business are as follows:
Fair value of assets acquired -
   
 
Accounts receivable
  $
57
 
Inventories
   
1,511
 
Other current assets
   
84
 
Property, plant and equipment
   
1,424
 
Goodwill
   
34,582
 
Other intangible assets (estimated useful life):
   
 
License agreement (10 years)
   
5,990
 
Technology (15 years)
   
34,136
 
Government grant (1.33 years)
   
800
 
         
   
78,584
 
Fair value of liabilities assumed -
   
 
Accounts payable and accrued expenses
   
1,058
 
         
Total consideration paid (including contingent
C
onsideration originally estimated at $27,202)
  $
77,526